Connect with us

CBD News

Canadian Cannabis Giant Cronos Group Sees Biggest Sales Potential in the US CBD Market



Canadian Cannabis Giant Cronos Group Sees Biggest Sales Potential in the US CBD Market

Toronto-based marijuana company Cronos Group anticipates that most of its CBD sales will come from the U.S. over the next few years. However, the company’s administrators cautioned investors not to speculate on how big the European CBD market will be this early.

These comments came when Cronos was releasing its first earnings report since the group announced its plans to spend $300 million in the United States’ hemp market through the acquisition of four Los Angeles-based Redwood Holding Group’s operating subsidiaries.

Michael Gorenstein, the CEO of Cronos, said that it is fair to estimate that the CBD market in the U.S. will be the greatest contributor to the company’s sales for the next one year or two. However, he warned against projecting the sales, arguing that it is still early to speculate how the European CBD market will unfold. According to Gorenstein, there is no enough clarity on the European CBD market as there is in the U.S. and the Canadian market.

The health regulators in Europe have made it clear that that CBD cannot be added to food. However, this is a decision that the European health regulators are seeking an appeal for.

Currently, Cronos trades as CRON on the Nasdaq and the Toronto Stock Exchange.

Cheryl Anne hails from Great Britain and casts a large shadow with her master’s degree in Relationship Therapy as well as a number of other professional accreditations. While she specializes in psychological thrillers and self-help books, her undeniable and uncanny knack for sifting through the cracks of the cannabis and CBD space are extremely necessary and sought after.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.